T细胞受体
生物
主要组织相容性复合体
细胞生物学
受体
肽
T细胞
血浆蛋白结合
信号转导
生物物理学
抗原
免疫系统
免疫学
生物化学
作者
Leah V. Sibener,Ricardo A. Fernandes,Elizabeth Motunrayo Kolawole,Catherine B. Carbone,Fan Liu,Darren B. McAffee,Michael E. Birnbaum,Xinbo Yang,Laura F. Su,Wong Yu,Shen Dong,Marvin H. Gee,Kevin M. Jude,Mark M. Davis,Jay T. Groves,William A. Goddard,James R. Heath,Brian D. Evavold,Ronald D. Vale,K. Christopher García
出处
期刊:Cell
[Elsevier]
日期:2018-07-01
卷期号:174 (3): 672-687.e27
被引量:254
标识
DOI:10.1016/j.cell.2018.06.017
摘要
TCR-signaling strength generally correlates with peptide-MHC binding affinity; however, exceptions exist. We find high-affinity, yet non-stimulatory, interactions occur with high frequency in the human T cell repertoire. Here, we studied human TCRs that are refractory to activation by pMHC ligands despite robust binding. Analysis of 3D affinity, 2D dwell time, and crystal structures of stimulatory versus non-stimulatory TCR-pMHC interactions failed to account for their different signaling outcomes. Using yeast pMHC display, we identified peptide agonists of a formerly non-responsive TCR. Single-molecule force measurements demonstrated the emergence of catch bonds in the activating TCR-pMHC interactions, correlating with exclusion of CD45 from the TCR-APC contact site. Molecular dynamics simulations of TCR-pMHC disengagement distinguished agonist from non-agonist ligands based on the acquisition of catch bonds within the TCR-pMHC interface. The isolation of catch bonds as a parameter mediating the coupling of TCR binding and signaling has important implications for TCR and antigen engineering for immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI